Ian D. Davis
伊恩·戴维斯
MBBS, PhD, FRACP
Professor of Medicine; Matthew Reeves Chair of Oncology医学教授；马修·里夫斯肿瘤学讲席教授
👥Biography 个人简介
Ian Davis is a leading Australian oncologist at Monash University and Eastern Health, best known for leading the ENZAMET trial that established enzalutamide in metastatic castration-sensitive prostate cancer. He also leads research in immunotherapy combinations for genitourinary cancers.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Enzalutamide in Castration-Sensitive Prostate Cancer
Led the ENZAMET phase III trial demonstrating enzalutamide plus testosterone suppression significantly improved overall survival in metastatic castration-sensitive prostate cancer, establishing a new global standard of care.
Representative Works 代表性著作
Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer (ENZAMET)
New England Journal of Medicine (2019)
Landmark international trial demonstrating overall survival benefit of enzalutamide in mCSPC, rapidly changing practice worldwide.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Hope S. Rugo
University of California, San Francisco (UCSF)
Maryam B. Lustberg
Yale School of Medicine / Yale Cancer Center
Sara M. Tolaney
Dana-Farber Cancer Institute / Harvard Medical School
Carlos H. Barrios
PUCRS (Pontifical Catholic University of Rio Grande do Sul) / Hospital São Lucas, Porto Alegre, Brazil
关注 伊恩·戴维斯 的研究动态
Follow Ian D. Davis's research updates
留下邮箱，当我们发布与 Ian D. Davis（Monash University and Eastern Health）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment